Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001255294-13-000296
Filing Date
2013-04-26
Accepted
2013-04-26 17:23:09
Documents
15
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-K/A 932608
2 EXHIBIT 10.32 ex10_32.htm EX-10.32 11590
3 EXHIBIT 10.33 ex10_33.htm EX-10.33 16591
4 EXHIBIT 10.34 ex10_34.htm EX-10.34 99327
5 EXHIBIT 10.35 ex10_35.htm EX-10.35 98234
6 EXHIBIT 31.1 ex31_1.htm EX-31.1 7828
7 EXHIBIT 31.2 ex31_2.htm EX-31.2 7743
8 EXHIBIT 32.1 ex32_1.htm EX-32.1 4420
9 EXHIBIT 32.2 ex32_2.htm EX-32.2 4080
  Complete submission text file 0001255294-13-000296.txt   7093010

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE ambse-20121231.xml EX-101.INS 1038480
11 XBRL SCHEMA FILE ambse-20121231.xsd EX-101.SCH 114771
12 XBRL CALCULATION FILE ambse-20121231_cal.xml EX-101.CAL 37141
13 XBRL DEFINITION FILE ambse-20121231_def.xml EX-101.DEF 119541
14 XBRL LABEL FILE ambse-20121231_lab.xml EX-101.LAB 384829
15 XBRL PRESENTATION FILE ambse-20121231_pre.xml EX-101.PRE 290961
Mailing Address 675 ALMANOR AVE. SUNNYVALE CA 94085
Business Address 675 ALMANOR AVE. SUNNYVALE CA 94085 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Filer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-148922 | Film No.: 13788431
SIC: 2834 Pharmaceutical Preparations